Tislelizumab (Tisle) combined with/without gemcitabine and cisplatin (GC) as adjuvant therapy in patients at high risk after upper urothelial carcinoma (UTUC) surgery: A realworld study

被引：0
|
作者：
Yang, Xiaojian [1 ]
Quan, Penghe [1 ]
Yu, Changjiang [1 ]
机构：
[1] Air Force Mil Med Univ, XIjing Hosp, Xian, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16592
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity
    Yong Luo
    Bingfu Feng
    Dechao Wei
    Yili Han
    Mingchuan Li
    Jiahui Zhao
    Yunhua Lin
    Zhu Hou
    Yongguang Jiang
    Scientific Reports, 10
  • [22] Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity
    Luo, Yong
    Feng, Bingfu
    Wei, Dechao
    Han, Yili
    Li, Mingchuan
    Zhao, Jiahui
    Lin, Yunhua
    Hou, Zhu
    Jiang, Yongguang
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Effect of adjuvant therapy on non-metastatic high risk upper urothelial carcinoma after radical nephroureterectomy: A single-center retrospective analysis
    Lu, Q.
    Yang, X.
    Li, K.
    Sun, H.
    EUROPEAN UROLOGY, 2023, 83 : S726 - S727
  • [24] Safety and efficacy of neoadjuvant immunotherapy with durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (gemcitabine/cisplatin or carboplatin) in patients with operable high-risk upper tract urothelial carcinoma.
    Houede, Nadine
    Chevallier, Thierry
    Loic, Jaffrelot
    Thibault, Constance
    Yann, Neuzillet
    Jaillon, Christine Abraham
    Masson-Lecomte, Alexandra
    Gravis, Gwenaelle
    Tartas, Sophie
    Pouessel, Damien
    Laguerre, Brigitte
    Audenet, Francois
    Xylinas, Evanguelos
    Guillaume, Luquiens
    Roupret, Morgan
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [25] TIDE: adjuvant tislelizumab plus donafenib combined with transarterial chemoembolization for high-risk hepatocellular carcinoma after surgery: protocol for a prospective, single-arm, phase II trial
    Qi, Weili
    Peng, Wei
    Qi, Xin
    Qiu, Zhancheng
    Wen, Tianfu
    Li, Chuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study
    Ikeda, Masaomi
    Matsumoto, Kazumasa
    Hirayama, Takahiro
    Koguchi, Dai
    Murakami, Yasukiyo
    Matsuda, Daisuke
    Okuno, Norihiko
    Utsunomiya, Takuji
    Taoka, Yoshinori
    Irie, Akira
    Iwamura, Masatsugu
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E669 - E675
  • [27] Updated results of the phase II ALTER-H004: Anlotinib combined with TACE as adjuvant therapy in hepatocellular carcinoma patients at high risk of recurrence after surgery
    Wu, Zheng
    Wang, Zheng
    Zhang, Lei
    Song, Xiaojing
    Du, Xilin
    Tan, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [28] Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer
    Greven, K
    Winter, K
    Underhill, K
    Fontenesci, J
    Cooper, J
    Burke, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 168 - 173
  • [29] A phase 2, multicenter study to evaluate the efficacy and safety of TACE sequential tislelizumab as adjuvant therapy in patients with HCC at high risk of recurrence after curative resection
    Liang, Tingbo
    Zhang, Zongli
    Zheng, Jinfang
    Wang, Yijun
    Zhang, Jialin
    Li, Bo
    Ma, Tao
    Xu, Yunfei
    Wu, Changxiong
    Sun, Quan
    Meng, Yiman
    Yang, Xiaoli
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study
    Xu, Tongpeng
    Bai, Jianan
    Zhao, Kun
    Chen, Xiaofeng
    Wang, Shuhui
    Zhu, Shusheng
    Sun, Chongqi
    Zhao, Chenhui
    Wang, Ting
    Zhu, Ling
    Hu, Meizhen
    Pang, Fei
    Zhang, Junling
    Wang, Wei
    Shu, Yongqian
    Li, Fang
    Zhou, Yue
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 9321 - 9331
12345